About Big Health
Big Health provides evidence-based, FDA-cleared digital treatments for insomnia disorder (SleepioRx1) and generalized anxiety disorder (DaylightRx2). These fully digital CBT-based treatments offer psychologists an accessible, scalable way to deliver first-line care. With new national billing codes effective January 1, 2025, SleepioRx and DaylightRx are reimbursable under Medicare Fee-for-Service and Medicare Advantage—expanding access to guideline-recommended mental health care.
FDA-cleared digital mental health treatments
Rooted in cognitive behavioral therapy—the gold-standard, first-line treatment recommended by the American Academy of Sleep Medicine and the Anxiety and Depression Association of America—SleepioRx and DaylightRx provide guideline-based care tailored to each patient. In clinical trials, 76% of SleepioRx users3 and 71% of DaylightRx users4 achieved clinical improvement in insomnia and anxiety, respectively, with lasting benefits beyond program completion.
Partner with Big Health
Big Health’s digital treatments empower psychologists to expand care delivery while maintaining clinical rigor. Learn how SleepioRx and DaylightRx can enhance your practice.
Handouts and resources
1. SleepioRx is a digital therapeutic intended for the treatment of chronic insomnia/insomnia disorder as an adjunct to usual care in patients aged 18 and older. SleepioRx is a prescription device delivering Cognitive Behavioral Therapy for Insomnia (CBT-I) and can be made available on the order of a licensed healthcare provider. Patients should read the instructions for use for full information.
2. DaylightRx is a prescription device delivering Cognitive Behavioral Therapy and can be made available on the order of a licensed healthcare provider. DaylightRx is a digital therapeutic intended to treat generalized anxiety disorder (GAD) by improving a patient's GAD symptoms as an adjunct to usual care in patients aged 22 years and older. Patients should read the instructions for use for full information.
3. Espie et al. (2012). Sleep, 35(6), 769–781opens in new window
4. Carl et al. (2020). Depression & Anxiety, 37(12), 1168–1178opens in new window
